ZymoBiotech
Latest round
- Series B
Last raised
- May 2026
Total raised
- $2.8M
Investors
- 6
About ZymoBiotech
, trading under the name ZymoBiotech, provides synthetic biology manufacturing and gene editing technology for the renewable energy and biomaterials sectors. The firm established a one-stop data analysis platform “ZymOmics” for Zymomonas mobilis and developed the GW-ICE circular gene editing system to produce compounds from non-food biomass. The company's founder is Professor Shihui Yang. The company works with energy and materials manufacturing enterprises to provide non-food synthetic biofuel and biomaterial products. The core business includes the proprietary ZymOmics platform, which provides services such as gene editing, biological component screening, and strain genotype and phenotype association analysis databases. Additionally, the company designs industrial strains utilizing agricultural straw and waste starch to produce bulk platform compounds such as fuel ethanol, lactic acid, 1,3-propanediol, isobutanol, and 1,4-butanediol. The company generates revenue by providing ZymOmics synthetic biology platform technology services and directly selling bulk alcohol and acid platform compounds through B2B contracts.
Who invested in ZymoBiotech
6 investors across 3 rounds
See all investors in ZymoBiotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ZymoBiotech
Who invested in ZymoBiotech?
ZymoBiotech has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ZymoBiotech raised?
ZymoBiotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ZymoBiotech last raise money?
ZymoBiotech's most recent round on record is a Series B, in May 2026.
What does ZymoBiotech do?
, trading under the name ZymoBiotech, provides synthetic biology manufacturing and gene editing technology for the renewable energy and biomaterials sectors.
Where is ZymoBiotech headquartered?
ZymoBiotech is headquartered in Wuhan, China.
Which VCs invest in companies like ZymoBiotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ZymoBiotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ZymoBiotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.